Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1960 2
1961 11
1962 13
1963 7
1964 8
1965 4
1966 11
1967 14
1968 17
1969 20
1970 14
1971 14
1972 11
1973 12
1974 18
1975 19
1976 15
1977 20
1978 27
1979 16
1980 20
1981 17
1982 28
1983 42
1984 38
1985 44
1986 45
1987 51
1988 53
1989 51
1990 43
1991 53
1992 53
1993 66
1994 56
1995 70
1996 53
1997 83
1998 57
1999 62
2000 72
2001 74
2002 81
2003 79
2004 72
2005 83
2006 88
2007 108
2008 127
2009 124
2010 128
2011 169
2012 165
2013 158
2014 124
2015 128
2016 159
2017 150
2018 161
2019 151
2020 216
2021 216
2022 183
2023 150
2024 74

Text availability

Article attribute

Article type

Publication date

Search Results

4,077 results

Results by year

Filters applied: . Clear all
Page 1
What causes hidradenitis suppurativa ?-15 years after.
Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. Zouboulis CC, et al. Among authors: fujita h. Exp Dermatol. 2020 Dec;29(12):1154-1170. doi: 10.1111/exd.14214. Exp Dermatol. 2020. PMID: 33058306 Free article. Review.
CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, Cui X, Kondo M, Hosoi T, Komidori S, Shimizu Y, Fujita H, Jiang L, Kong Y, Yamanashi T, Seita J, Yamamoto T, Toyokuni S, Hamazaki Y, Hattori M, Yoshikai Y, Boor P, Floege J, Kawamoto H, Murakawa Y, Minato N, Yanagita M. Sato Y, et al. Among authors: fujita h. J Clin Invest. 2022 Jan 18;132(2):e146071. doi: 10.1172/JCI146071. J Clin Invest. 2022. PMID: 34813503 Free PMC article.
ER proteostasis regulators cell-non-autonomously control sleep.
Kawano T, Kashiwagi M, Kanuka M, Chen CK, Yasugaki S, Hatori S, Miyazaki S, Tanaka K, Fujita H, Nakajima T, Yanagisawa M, Nakagawa Y, Hayashi Y. Kawano T, et al. Among authors: fujita h. Cell Rep. 2023 Mar 28;42(3):112267. doi: 10.1016/j.celrep.2023.112267. Epub 2023 Mar 15. Cell Rep. 2023. PMID: 36924492 Free article.
Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
Sootome H, Fujita H, Ito K, Ochiiwa H, Fujioka Y, Ito K, Miura A, Sagara T, Ito S, Ohsawa H, Otsuki S, Funabashi K, Yashiro M, Matsuo K, Yonekura K, Hirai H. Sootome H, et al. Among authors: fujita h. Cancer Res. 2020 Nov 15;80(22):4986-4997. doi: 10.1158/0008-5472.CAN-19-2568. Epub 2020 Sep 24. Cancer Res. 2020. PMID: 32973082
Diagnosis of Generalized Pustular Psoriasis.
Fujita H, Gooderham M, Romiti R. Fujita H, et al. Am J Clin Dermatol. 2022 Jan;23(Suppl 1):31-38. doi: 10.1007/s40257-021-00652-1. Epub 2022 Jan 21. Am J Clin Dermatol. 2022. PMID: 35061226 Free PMC article. Review.
MARCH8: the tie that binds to viruses.
Tada T, Zhang Y, Fujita H, Tokunaga K. Tada T, et al. Among authors: fujita h. FEBS J. 2022 Jul;289(13):3642-3654. doi: 10.1111/febs.16017. Epub 2021 May 31. FEBS J. 2022. PMID: 33993615 Free article. Review.
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: fujita h. Nat Cancer. 2023 Sep;4(9):1345-1361. doi: 10.1038/s43018-023-00630-y. Epub 2023 Sep 21. Nat Cancer. 2023. PMID: 37743366 Free PMC article.
4,077 results